Program:
Continued Breakthroughs and Clinical Trials.
* Comprehensive, solution-based sessions by world-renowned
industry leaders
* Get the latest results of ongoing research and clinical trials.
* Hear from the experts about the future of COX-2 Inhibitors.
Registration :
Deadline for Abstracts: March 8, 1999
Email for Requests and Registration: inq@ibcusa.com